{
    "clinical_study": {
        "@rank": "46935", 
        "arm_group": {
            "arm_group_label": "DeltaMaxx treated Patients"
        }, 
        "brief_summary": {
            "textblock": "The primary objective of this registry is to assess the safety and angiographic outcomes of\n      endovascular treatment of intracranial aneurysms using the DeltaMaxx Microcoil System."
        }, 
        "brief_title": "Evaluation of DeltaMaxx\u00ae Microcoil System in Intracranial Aneurysms", 
        "condition": "Intracranial Aneurysms", 
        "condition_browse": {
            "mesh_term": [
                "Aneurysm", 
                "Intracranial Aneurysm"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Subject age \u226518 and \u226480 with a diagnosis of ruptured or unruptured intracranial\n             aneurysm judged suitable for selective endovascular treatment by coil occlusion\n             during single procedure\n\n          -  Investigator intends to use DeltaMaxx Microcoil system during coiling procedure\n\n          -  Investigator intends to use only Codman Neuro microcoils during coiling procedure\n\n          -  Aneurysm size [largest measurement from the cross sectional images to determine\n             overall aneurysm size, not just the lumen] \u22656 mm\n\n          -  If ruptured aneurysm: Hunt and Hess 1, 2, or 3\n\n          -  If unruptured aneurysm: Subject grade Modified Rankin Scale 0 - 2\n\n          -  The subject or his/her Legally Authorized Representative must voluntarily provide\n             Informed Consent for participation in this study and agree to return for all study\n             visits.\n\n        Exclusion Criteria:\n\n          -  Prior treatment (surgical or endovascular) of the target aneurysm\n\n          -  Subjects with more than one aneurysm (>2 mm) that have been treated with endovascular\n             or clipping techniques in the past 30 days.\n\n          -  Subject with social, medical or psychological conditions that interfere with\n             treatment and follow-up evaluation\n\n          -  Women who are pregnant or plan to become pregnant during the study\n\n          -  Life expectancy less than 12 months.\n\n          -  Presence of arteriovenous malformation\n\n          -  Fusiform, mycotic, traumatic, or tumoral aneurysms\n\n          -  Planned aneurysm treatment by parent vessel occlusion\n\n          -  Subject enrolled in any concurrent study"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "80 Years", 
            "minimum_age": "18 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "Subjects who have been diagnosed with a \u2265 6 mm intracranial aneurysm."
            }
        }, 
        "enrollment": {
            "#text": "150", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 12, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01945827", 
            "org_study_id": "CD-000036-PRO"
        }, 
        "intervention": {
            "arm_group_label": "DeltaMaxx treated Patients", 
            "intervention_name": "DeltaMaxx Microcoil System", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "January 27, 2014", 
        "number_of_groups": "1", 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "The Primary Effectiveness endpoint is the immediate post-procedure and 12-month angiographic occlusion rates assessed by the independent core lab using the modified Raymond-Roy Grading Scale (RRGS) scale", 
                "measure": "Primary Effectiveness Objective - Angiographic  Outcomes", 
                "safety_issue": "No", 
                "time_frame": "12 Months"
            }, 
            {
                "description": "Neurological Morbidity and Mortality as determined by the NIH Stroke Scale and all-cause mortality, regardless of relationship to the treatment, will be captured over the course of the study", 
                "measure": "Primary Safety Endpoint - Neurological Morbidity and Mortality", 
                "safety_issue": "Yes", 
                "time_frame": "12 months"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01945827"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Packing density as measured by volumetric filling of the aneurysm post-procedure after the coils have been placed as indicated by angiographic films taken at the end of the coiling procedure", 
                "measure": "Packing Density", 
                "safety_issue": "No", 
                "time_frame": "24 hours"
            }, 
            {
                "measure": "Recurrence Rate", 
                "safety_issue": "No", 
                "time_frame": "12 months"
            }, 
            {
                "measure": "Re-treatment Rate", 
                "safety_issue": "No", 
                "time_frame": "12 months"
            }
        ], 
        "source": "Codman & Shurtleff", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Codman & Shurtleff", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "January 2014", 
        "study_design": "Observational Model: Case-Only, Time Perspective: Prospective", 
        "study_type": "Observational [Patient Registry]", 
        "target_duration": "12 Months", 
        "verification_date": "January 2014"
    }
}